Previous 10 | Next 10 |
BioTelemetry, Inc. (BEAT) Q1 2020 Earnings Conference Call May 6, 2020 5:00 PM ET Company Participants Joseph Capper - President and Chief Executive Officer Heather Getz - Chief Financial Officer Conference Call Participants Brooks O’Neil - Lake Street Capital Markets ...
BioTelemetry (NASDAQ: BEAT ): Q1 Non-GAAP EPS of $0.45 beats by $0.02 ; GAAP EPS of $0.19 misses by $0.02 . Revenue of $113.03M (+8.7% Y/Y) beats by $0.13M . Press Release More news on: BioTelemetry, Inc., Earnings news and commentary, Healthcare stocks news,
MALVERN, Pa., May 06, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the quarter ended March 31, 2020. ...
MALVERN, Pa., April 29, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its first quarter 2020 earnings on Wednesday, May 6 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Wednesday, May 6, 2020. The b...
MALVERN, Pa., April 27, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that its 2020 Annual Meeting of Stockholders wil...
MALVERN, Pa., April 07, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that Dr. Andrei Stoica has been named Chief Tech...
MALVERN, Pa., March 25, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), a leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today announced the activation of an expanded service using its Mo...
BioTelemetry, Inc. (BEAT) Q4 2019 Earnings Conference Call February 26, 2020, 05:00 PM ET Company Participants Joseph Capper - President and CEO Heather Getz - CFO Conference Call Participants Kaila Krum - SunTrust Frank Takkinen - Lake Street Capital Jayson Bedford - Ray...
BioTelemetry (NASDAQ: BEAT ): Q4 Non-GAAP EPS of $0.48 beats by $0.21 ; GAAP EPS of $0.04. More news on: BioTelemetry, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Announces Record Quarterly and Full Year Results MALVERN, Pa., Feb. 26, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today report...
News, Short Squeeze, Breakout and More Instantly...
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has been added to the Russell Microcap(R) Index. The move was effective after market close on June 28, 2024, and is part of FTSE Russell’s annual reconst...
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, today announced that it has been added to the Russell Microcap® Index effective after the market close on June 28, 2024 as part of FTSE Russell...
HeartBeam (NASDAQ: BEAT) , a medical technology company focused on transforming cardiac care through the power of personalized insights, today announced the results of a new study demonstrating that HeartBeam AI combined with vectorcardiography (“VCG”) outperformed an expert panel o...